Castelli Jeff

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$300,182.87
Insider Sells Quantity
12
Insider Sells Sum
$2.48M

Insider Activity of Castelli Jeff

According to the SEC Form 4 filings, Castelli Jeff, being in a position of

  1. Chief Development Officer at Amicus Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 17421 share for $252,902,
    over all time since 2014-10-02, has bought 53726 shares for $300,183, and sold 225953 shares for $2.48M.

The largest purchase of all time was on 2014-10-03 and amounted to 17104 shares of Amicus Therapeutics, Inc. for $119,728.

The largest sale of all time was on 2015-06-22 and amounted to 37962 shares of Amicus Therapeutics, Inc. for $529,255.

Biography of Castelli Jeff

No biography is available at this moment.

2023-12-28SaleAmicus Therapeutics, Inc.
FOLD
Chief Development Officer
17,421
0.006%
$14.52$252,902-24.22%
2023-12-20SaleAmicus Therapeutics, Inc.
FOLD
Chief Development Officer
1,654
0.0006%
$13.10$21,667-13.68%
2023-12-19SaleAmicus Therapeutics, Inc.
FOLD
Chief Development Officer
17,500
0.006%
$13.25$231,875-15.3%
2015-06-22SaleAmicus Therapeutics, Inc.
FOLD
SVP, Program Management
37,962
0.038%
$13.94$529,255-41.74%
2015-06-15SaleAmicus Therapeutics, Inc.
FOLD
SVP, Program Management
14,754
0.0149%
$14.17$209,064-41.07%
2015-06-08SaleAmicus Therapeutics, Inc.
FOLD
SVP, Program Management
34,624
0.0341%
$12.87$445,611-33.46%
2015-05-11SaleAmicus Therapeutics, Inc.
FOLD
SVP, Program Management
20,000
0.0201%
$10.84$216,742-10.41%
2015-04-01SaleAmicus Therapeutics, Inc.
FOLD
VP, Program Management
18,978
0.0185%
$10.69$202,960-3.18%
2015-01-05SaleAmicus Therapeutics, Inc.
FOLD
VP, Program Management
9,334
0.008%
$7.16$66,855+22.92%
2014-11-25SaleAmicus Therapeutics, Inc.
FOLD
VP, Program Management
16,206
0.0158%
$5.76$93,428+35.35%
2014-11-25PurchaseAmicus Therapeutics, Inc.
FOLD
VP, Program Management
16,206
0.0158%
$5.76$93,428+35.35%
2014-10-03SaleAmicus Therapeutics, Inc.
FOLD
VP, Program Management
17,104
0.0231%
$7.00$119,728+53.08%
2014-10-03PurchaseAmicus Therapeutics, Inc.
FOLD
VP, Program Management
17,104
0.0231%
$7.00$119,728+53.08%
2014-10-02SaleAmicus Therapeutics, Inc.
FOLD
VP, Program Management
20,416
0.0178%
$4.26$87,027+62.58%
2014-10-02PurchaseAmicus Therapeutics, Inc.
FOLD
VP, Program Management
20,416
0.0178%
$4.26$87,027+62.58%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.